[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-460575-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-460575-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeting-the-tfamcgassting-axis-a-mitochondrialinflammatory-link-in-the-pathogenesis-and-treatment-of-diabetic-kidney-disease","Targeting the TFAM‑cGAS‑STING axis - a mitochondrial‑inflammatory link in the pathogenesis and treatment of diabetic kidney disease","","Diabetic kidney disease (DKD) is a widespread and severe complication of diabetes, with its pathogenic basis not fully resolved. Mitochondrial dysfunction is increasingly implicated in DKD onset and progression. Mitochondrial transcription factor A (TFAM), a regulator of mitochondrial DNA (mtDNA) expression, helps maintain mitochondrial integrity and suppress mtDNA leakage. By preventing activation of the cGAS–STING inflammatory pathway, TFAM-related mechanisms may reduce renal inflammation and fibrosis. Targeting the TFAM–cGAS–STING axis is proposed as a promising therapeutic and mechanistic research direction.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-the-tfamcgassting-axis-a-mitochondrialinflammatory-link-in-the-pathogenesis-and-treatment-of-diabetic-kidney-disease/460575/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-the-tfamcgassting-axis-a-mitochondrialinflammatory-link-in-the-pathogenesis-and-treatment-of-diabetic-kidney-disease/460575.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-30",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",19,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of this review?","Question",{"text":63,"@type":64},"The review examines how TFAM stabilizes mitochondrial function and prevents mtDNA leakage to inhibit the cGAS–STING pathway, linking mitochondrial dysfunction to DKD pathogenesis and potential treatment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why is mitochondrial dysfunction important in diabetic kidney disease?",{"text":68,"@type":64},"Mitochondrial dysfunction is described as a key pathogenic driver in DKD, associated with disrupted energy metabolism, increased oxidative stress, and activation of proinflammatory signaling pathways.",{"name":70,"@type":61,"acceptedAnswer":71},"How does targeting the TFAM–cGAS–STING axis help in DKD?",{"text":72,"@type":64},"Suppressing cGAS–STING activation is stated to alleviate renal inflammation and fibrosis, and targeting TFAM–cGAS–STING signaling is presented as a promising strategy given the lack of curative therapies.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},460575,1791031735,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","International Urology and Nephrology (2026) 58:179–187  \n[https://doi.org/10.1007/s1](https://doi.org/10.1007/s1) 1255-025-04651-7  \nTargeting the TFAM‑cGAS‑STING axis: a mitochondrial‑inflammatory link in the pathogenesis and treatment of diabetic kidney disease  \nJingting Yun1 · Jinyi Shan1 · Ji Li1  \nReceived: 21 May 2025 / Accepted: 6 July 2025 / Published online: 14 July 2025 © The Author(s) 2025  \nAbstract  \nDiabetic kidney disease (DKD) is one of the common and devastating chronic complications of diabetes, its pathogenesis remains incompletely understood. Emerging evidence suggests that mitochondrial dysfunction plays a crucial role in the onset and progression of DKD. Mitochondrial transcription factor A (TFAM), a key regulator of mitochondrial DNA (mtDNA) expression, is essential for maintaining mitochondrial integrity and function, and is increasingly recognized for its role in modulating inflammatory signaling. This review focuses on the regulatory mechanisms by which TFAM stabilizes mitochondrial function and prevents mtDNA leakage, thereby inhibiting activation of the cyclic GMP–AMP synthase–stimulator of interferon genes (cGAS–STING) pathway. Suppression of this pathway has been shown to alleviate renal inflammation and fibrosis. Given the current lack of curative therapies for DKD, targeting the TFAM–cGAS–STING signaling axis represents a promising novel strategy for both therapeutic intervention and mechanistic research in DKD.  \nKeywords Diabetic kidney disease · TFAM · cGAS–STING pathway · Mitochondrial dysfunction · Inflammation  \nIntroduction  \nDiabetic kidney disease (DKD) is one of the most severe microvascular complications of diabetes and a leading cause of both end-stage renal disease (ESRD) and chronic kidney disease (CKD) [1, 2] . In addition, DKD significantly increases the risk of cardiovascular disease in diabetic patients, making it a critical contributor to morbidity and mortality in this population [3] . Although considerable progress has been made in understanding DKD, its underlying pathogenic mechanisms remain incompletely elucidated. The global incidence of DKD continues to rise, with approximately 40% of individuals with diabetes eventually developing the disease [4] . This imposes a substantial burden on healthcare systems and significantly impairs the life quality of patients. Clinically, DKD is characterized by persistent albuminuria, a progressive decline in glomerular filtration rate (GFR), increased extracellular matrix deposition, and podocyte injury and loss [5–8] . Current therapeutic approaches primarily involve renin–angiotensin–aldosterone  \n* Ji Li[hljzyylj@126.com](hljzyylj@126.com)  \n1 Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China  \nsystem (RAAS) inhibitors and sodium–glucose cotransporter 2 (SGLT2) inhibitors to delay disease progression. However, these treatments provide only partial benefits and fail to offer a definitive cure. Therefore, there is an urgent need for more effective therapeutic strategies to overcome the current clinical limitations.  \nMitochondria are dynamic organelles with diverse cellular functions, playing a central role in necrosis, apoptosis, and energy metabolism. Mitochondrial dysfunction has been implicated in the pathogenesis of various organ-specific diseases, including those affecting the heart, lungs, liver, kidneys, and skeletal muscle [9 , 10] . The kidneys are particularly dependent on mitochondrial adenosine triphosphate (ATP) production to sustain their high metabolic demands. Consequently, mitochondrial impairment reduces renal metabolic efficiency and heightens disease susceptibility [11] . In DKD, mitochondrial dysfunction is considered a key pathogenic driver, characterized by disrupted energy metabolism, increased oxidative stress, and activation of proinflammatory signaling pathways [12–15] . Mitochondrial transcription factor A (TFAM) is a nuclear-encoded protein critical for mitochondrial DNA (mtDNA) re","cbCairFDUYlzEY16","https://ap.wps.com/l/cbCairFDUYlzEY16","pdf",759559,"English","# Introduction\n## Diabetic kidney disease and current therapeutic limitations\n## Mitochondrial dysfunction in DKD\n## TFAM and mitochondrial DNA homeostasis\n## cGAS–STING pathway in innate immunity and inflammation\n# Pathogenesis of DKD: the interplay between mitochondrial dysfunction and inflammation\n## Mitochondrial damage in the development of DKD\n## Susceptibility of mtDNA to oxidative damage","[{\"question\":\"What is the main focus of this review?\",\"answer\":\"The review examines how TFAM stabilizes mitochondrial function and prevents mtDNA leakage to inhibit the cGAS–STING pathway, linking mitochondrial dysfunction to DKD pathogenesis and potential treatment.\"},{\"question\":\"Why is mitochondrial dysfunction important in diabetic kidney disease?\",\"answer\":\"Mitochondrial dysfunction is described as a key pathogenic driver in DKD, associated with disrupted energy metabolism, increased oxidative stress, and activation of proinflammatory signaling pathways.\"},{\"question\":\"How does targeting the TFAM–cGAS–STING axis help in DKD?\",\"answer\":\"Suppressing cGAS–STING activation is stated to alleviate renal inflammation and fibrosis, and targeting TFAM–cGAS–STING signaling is presented as a promising strategy given the lack of curative therapies.\"}]","Targeting the TFAM‑cGAS‑STING axis - a mitochondrial‑inflammatory link in the pathogenesis and treatment of diabetic kidney disease | PDF",1790758810,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/e52af98311c4953b8955990938382389.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/ee582bd321d60d3792e2edf55df61f9e.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/38238d26822b10106f1f4151c0a08b72.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/b64210e1b4ca283e3f32eb6b78e2afc1.webp",980,1301]